Who has invested in Bohai New Enzyme?

Gf Securities, GL Capital, CASH Capital are named among the investors backing Bohai New Enzyme.

Bohai New Enzyme Funding: $2.2M Raised, Series C (2021)

Bohai New Enzyme funding overview

Bohai New Enzyme is based in Wuhan, China. Bohai New Enzyme has raised $2.2M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series C announced in November 2021. The round record for Bohai New Enzyme runs through 2021; nothing later has been disclosed. Investors on record include Gf Securities, GL Capital, CASH Capital. 3 distinct backers are named across the disclosed rounds.

Bohai New Enzyme at a glance

Total raised: $2.2M
Latest round: Series C
Latest round date: November 2021
Headquarters: Wuhan, China
Notable investors: Gf Securities, GL Capital, CASH Capital

Frequently asked about Bohai New Enzyme funding

How much has Bohai New Enzyme raised?: Bohai New Enzyme has raised $2.2M in total disclosed funding across the rounds on record.
Who has invested in Bohai New Enzyme?: Gf Securities, GL Capital, CASH Capital are named among the investors backing Bohai New Enzyme.
What was the latest Bohai New Enzyme funding round?: The most recent disclosed round is a Series C, announced in November 2021.
Where is Bohai New Enzyme based?: Bohai New Enzyme is based in Wuhan, China.
When did Bohai New Enzyme last raise?: The last disclosed Bohai New Enzyme round closed in November 2021 at Series C.

Round data for Bohai New Enzyme is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Wuhan and backer lists below.

Bohai New Enzyme Funding: $2.2M Raised, Series C (2021)

Bohai New Enzyme funding overview

Bohai New Enzyme at a glance

Frequently asked about Bohai New Enzyme funding

Companies related to Bohai New Enzyme (40)

Browse related funding lists (3)